Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 297,680
  • Shares Outstanding, K 48,800
  • Annual Sales, $ 0 K
  • Annual Income, $ -63,730 K
  • EBIT $ -64 M
  • EBITDA $ -61 M
  • 60-Month Beta 1.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.72

Options Overview Details

View History
  • Implied Volatility 136.35% ( +56.06%)
  • Historical Volatility 99.75%
  • IV Percentile 63%
  • IV Rank 37.53%
  • IV High 334.35% on 02/20/25
  • IV Low 17.40% on 09/06/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 1,852
  • Volume Avg (30-Day) 3,426
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 45,175
  • Open Int (30-Day) 21,980

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.36
  • Number of Estimates 5
  • High Estimate -0.32
  • Low Estimate -0.43
  • Prior Year -0.75
  • Growth Rate Est. (year over year) +52.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.66 +30.90%
on 04/21/25
7.32 -16.71%
on 04/30/25
+1.25 (+25.77%)
since 04/16/25
3-Month
3.93 +55.22%
on 04/09/25
7.32 -16.71%
on 04/30/25
+0.08 (+1.33%)
since 02/14/25
52-Week
3.93 +55.22%
on 04/09/25
7.32 -16.71%
on 04/30/25
+1.50 (+32.61%)
since 05/16/24

Most Recent Stories

More News
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

ABEO : 6.10 (+5.35%)
UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 6.10 (+5.35%)
U.S. FDA Approves ZEVASKYNâ„¢ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

ABEO : 6.10 (+5.35%)
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

ABEO : 6.10 (+5.35%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 6.78
2nd Resistance Point 6.45
1st Resistance Point 6.28
Last Price 6.10
1st Support Level 5.77
2nd Support Level 5.44
3rd Support Level 5.26

See More

52-Week High 7.32
Last Price 6.10
Fibonacci 61.8% 6.03
Fibonacci 50% 5.63
Fibonacci 38.2% 5.23
52-Week Low 3.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar